TforG prides itself in actively and passionately following, studying and understanding the latest developments in global healthcare markets. This year, for the 25th year in a row, we visited one of the world’s largest and most international trade forums, MEDICA, in Germany. Top decision makers from around the world come together at MEDICA and see […]
Home > News
TforG will be attending EUS – Endo 2017, the International Live Course event in Marseille on the 28th – 29th September 2017, and the 25th UEG Week on the 28th – 30th October 2017, in Barcelona.
TforG was in London this month to hear how innovative healthcare technology can enable positive outcomes for patients, practitioners, companies and payers alike at the HealthTechX Europe 2017 summit. Key industry leaders, thinkers and visionaries took to the stage to address current trends and challenges facing global healthcare and showcasing the latest innovative technologies set […]
TforG, represented by its recently appointed new business development lead, Natalie Christie, was in Düsseldorf last week attending the world’s biggest medical trade fair, MEDICA 2016, featuring 5,000 exhibitors from approximately 70 countries from around the globe.
Across the globe –whether evaluating an emerging market or a highly industrialized economy – one principle driving factor of healthcare administration and commercial markets is consistently the same. In a nutshell, growing numbers of patients, paired with financial constraints, growing healthcare costs and patient demand/expectations, all intertwined with the challenge of rising chronic illnesses and […]
In a previous blog “Which way to go in tomorrow’s MedTech markets“, we described how different forces are placing the national healthcare systems and the MedTech and pharmaceutical industries under substantial pressure. In this second blog of this series, we offer further insights into our exploration of the healthcare market and our answers to the […]
In 2015, global healthcare (HC) spending represented almost €7.5 trillion (11% of the world’s GDP), expected to grow almost 6% in the 3 years to come. National Health Care Systems and Care Providers, worldwide, are migrating to some level of integrated care. MedTech companies want to follow, but wonder which direction will generate the highest […]
It wasn’t even that long ago that the world of the MedTech market was relatively simple to read. Recognizable competitive challenges, evolutionary developments; a world that we were familiar with and were able to map the developments of for 5 years at a time -and when accepting a certain margin of uncertainty- possibly forecast even […]
As we have discussed in a previous blog, some of the key success factors of effective, efficient and added-value market research deal with identifying and accessing the appropriate, i.e. representative, respondents. Furthermore, once the appropriate respondent group is reached, it is crucial to lead a meaningful discussion that explores, addresses and understands the key drivers, […]
In a turbulent medtech market, “evidence-based decision making” has become a standard practice. Clinical pathways and treatment scenarios change rapidly, pressured by new technologies and methodologies. Even more so, they are pressured by different reimbursement rules, by the increasing intervention of healthcare insurers, and by the shifts in priorities of hospital managers, who are seeking […]